Zhang Jj H, Starr Savannah L, Chamie Karim
Department of Urology, UCLA Medical Center, Los Angeles, CA, USA.
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Bladder Cancer. 2023 Jun 27;9(2):109-123. doi: 10.3233/BLC-220114. eCollection 2023.
Systemic agents including immune checkpoint inhibitors, antibody-drug conjugates, and targeted therapies play a critical role in the management of bladder cancer. Novel localized delivery mechanisms for existing systemic agents explore solutions to improve treatment response without compromising safety. Herein, we review the contemporary innovations in modern intravesical agents, hyperthermic drug delivery, reverse-thermal gels, nanocarriers, gene therapy, and subcutaneous therapies.
包括免疫检查点抑制剂、抗体药物偶联物和靶向疗法在内的全身用药在膀胱癌治疗中发挥着关键作用。针对现有全身用药的新型局部给药机制探索了在不影响安全性的前提下改善治疗反应的解决方案。在此，我们综述了现代膀胱内用药、热疗药物递送、逆温凝胶、纳米载体、基因治疗和皮下治疗方面的当代创新成果。
